About Natrox
Natrox is a company based in Waterbeach (United Kingdom) founded in 2003. Natrox has raised $68.39 million across 22 funding rounds from investors including Amadeus Capital Partners, Meltwind Advisory and Puhua Capital. Natrox operates in a competitive market with competitors including EO2Concepts, Vaporox, Advanced Oxygen Therapy, InotecAMD and Numobag, among others.
- Headquarter Waterbeach, United Kingdom
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Inotec Amd Limited
- Date of Incorporation 23 Dec, 2003
- Jurisdiction CAMBRIDGE, ENGLAND
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$68.39 M (USD)
in 22 rounds
-
Latest Funding Round
$33 M (USD), Series C
Dec 02, 2024
-
Investors
Amadeus Capital Partners
& 5 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Natrox
Unlock access to complete
Unlock access to complete
Funding Insights of Natrox
Natrox has successfully raised a total of $68.39M across 22 strategic funding rounds. The most recent funding activity was a Series C round of $33 million completed in December 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Natrox
Natrox has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Amadeus Capital Partners, Meltwind Advisory and Puhua Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage deep technology investments are made by Amadeus Capital.
|
Locked | Locked | Locked | |
|
Health and technology startups are invested in by Puhua Capital.
|
Locked | Locked | Locked | |
|
Venture capital funding is provided by Praetura Ventures.
|
Locked | Locked | Locked |
Investor details for Natrox
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Natrox
Investment portfolio details for Natrox
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Natrox
Detailed financials for Natrox
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Natrox Comparisons
Peer comparison for Natrox
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Natrox
Natrox operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as EO2Concepts, Vaporox, Advanced Oxygen Therapy, InotecAMD and Numobag, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Continuous oxygen diffusion devices for chronic wound care are developed.
|
|
| Locked | Locked | Locked |
Developer of medical device for the wound treatment
|
|
| Locked | Locked | Locked |
Solutions for treating severe acute and chronic wounds are developed.
|
|
| Locked | Locked | Locked |
Chronic wound solutions are developed via portable oxygen-enrichment devices.
|
|
| Locked | Locked | Locked |
Topical hyperbaric oxygen therapy for wound healing is developed.
|
Detailed competitors of Natrox
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Natrox
Complete news archive for Natrox
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Natrox
Natrox was founded in 2003 and raised its 1st funding round 2 years after it was founded.
Natrox is headquartered in Waterbeach, United Kingdom. It is registered at Waterbeach, Cambridgeshire, United Kingdom.
Gordie Nye is the current CEO of Natrox.
Natrox is a funded company, having raised a total of $68.39M across 22 funding rounds to date.
Founded in 2003 and based in Waterbeach, United Kingdom, Natrox operates in the medical device sector focused on wound care. The NATROX device is developed, featuring an oxygen generator and delivery system that supplies oxygen to wounds through a single-use secondary dressing to aid healing in chronic cases. A cloud-based platform is also provided for clinical teams to capture and access patient wound care data.
Natrox's top competitors include Vaporox, Advanced Oxygen Therapy and EO2Concepts.
Natrox has 6 investors. Key investors include Amadeus Capital Partners, Meltwind Advisory, Puhua Capital, WealthClub, and Praetura Ventures.
The valuation of Natrox is $31.98M as of Nov 2019.